Cresset Asset Management, LLC Ensysce Biosciences, Inc. Transaction History

Cresset Asset Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$100.8 - $345.6 $1.13 Million - $3.88 Million	-11,223 Closed	0 $0
Q4 2021 Feb 10, 2022	SELL	$300.0 - $1228.8 $748,200 - $3.06 Million	-2,494 Reduced 18.18%	11,223 $53,000
Q3 2021 Nov 15, 2021	BUY	$696.0 - $3477.6 $9.55 Million - $47.7 Million	13,717 New	13,717 $42,000

100

Ticker ENSC
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,918,900
Market Cap $1.25M
Description
Ensysce Biosciences, Inc., a clinical-stage pharmaceutical company, engages in developing various prescription drugs for severe pain relief in opioid addiction, misuse, abuse, and overdose in the United States. It develops products using Trypsin Activated Abuse Protection platform, an abuse-resistant opioid prodrug technology; and Multi-Pill Abu...

Get notified when there are updates to the investment portfolio of Cresset Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Cresset Asset Management, LLC with notifications on news.